Werner Lanthaler
Direktor/Vorstandsmitglied bei AC IMMUNE SA
Vermögen: 16 Mio $ am 30.04.2024
Ursprung des Netzwerks ersten Grades von Werner Lanthaler
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
31
| Public Company | Pharmaceuticals: Major | 31 |
28
| Public Company | Pharmaceuticals: Major | 28 |
26
| Public Company | Pharmaceuticals: Other | 26 |
Intercell AG
 Intercell AG Pharmaceuticals: MajorHealth Technology Intercell AG engages in the research, development, manufacture, and marketing of novel vaccines for the prevention and treatment of infectious diseases. Its products include Japanese encephalitis vaccine, Pseudomonas vaccine, Clostridium difficile vaccine, tuberculosis vaccine, and pandemic influenza vaccine patch. Its technology platforms involve patch-based delivery system and proprietary human monoclonal antibody discovery system. The company was founded by Alexander von Gabain, Max Birnstiel, Michael Buschle, Walter Schmidt, and Aaron Hirsh on December 3, 1997 and is headquartered in Vienna, Austria.
9
| Extinct | Pharmaceuticals: Major | 9 |
Topas Therapeutics GmbH
 Topas Therapeutics GmbH Pharmaceuticals: MajorHealth Technology Topas Therapeutics GmbH engages in pharmaceutical preparations. The company is headquartered in Hamburg, Germany.
3
| Holding Company | Pharmaceuticals: Major | 3 |
Evotec (UK) Ltd.
 Evotec (UK) Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Evotec SE, Evotec (UK) Ltd. provides research and development on natural sciences and engineering. The company is based in Abingdon, UK and was founded in 1991.
3
| Subsidiary | Miscellaneous Commercial Services | 3 |
Federation of Austrian Industry
 Federation of Austrian Industry Miscellaneous Commercial ServicesCommercial Services The Federation of Austrian Industry is an organization that focuses on the observation and analysis of international developments, trade and investment agreements, and the conditions of fair international competition. The non-profit company is based in Vienna, Austria. Austria is a small but highly export-oriented economy, and the organization believes that for the future growth and prosperity of the country, its companies must have the best possible framework to take advantage of their international opportunities. The organization emphasizes the importance of sustainable international relationships and free and fair trade to ensure Austria's export capability and access to markets. The CEO of the Austrian company is Martin Ohneberg.
2
| Non-Profit Organization | Miscellaneous Commercial Services | 2 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Werner Lanthaler
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| AMGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| BAYER AG | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Director/Board Member | |
| 2INVEST AG | Financial Conglomerates | Director/Board Member Director/Board Member | |
| NOVO NORDISK A/S | Pharmaceuticals: Major | Corporate Officer/Principal Director/Board Member Corporate Officer/Principal Corporate Officer/Principal | |
Novartis International AG
 Novartis International AG Pharmaceuticals: MajorHealth Technology Novartis International AG manages the Novartis Group. It provides administrative, financial, legal, and technical services. It also offers scientific consultation to the Group. The company was founded on December 13, 1989 and is headquartered in Basel, Switzerland. | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
Cyprotex Discovery Ltd.
 Cyprotex Discovery Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Evotec SE, Cyprotex Discovery Ltd. is a British company that specializes in in vitro toxicology studies using a range of techniques such as cell-based assays, mass spectrometer, fluorescence imaging, and qrt-pcr endpoints. The company is based in Abingdon, UK. The company also offers mitochondrial toxicity assays including seahorse assay, glu/gal assay, mitochondrial biogenesis, mitochondrial membrane potential, and mitochondrial mass. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| NOVARTIS AG | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| The Trustees of Columbia University in The City of New York | College/University | Undergraduate Degree Undergraduate Degree | |
Duke University
 Duke University Other Consumer ServicesConsumer Services Duke University is an academic university that offers undergraduate, graduate and professional programs. It also has publications and research services. The university was founded in 1838 and is headquartered in Durham, NC. | College/University | Corporate Officer/Principal Corporate Officer/Principal Graduate Degree | |
| Stanford University | College/University | Graduate Degree Undergraduate Degree | |
| UCB | Pharmaceuticals: Major | Director/Board Member Chief Tech/Sci/R&D Officer | |
| ACTIVE BIOTECH AB | Biotechnology | Director/Board Member Chairman Director/Board Member | |
Novo Holdings AS (Denmark)
 Novo Holdings AS (Denmark) Financial ConglomeratesFinance Novo Holding A/S provides financial investments and manages the Novo Nordisk Foundation?s assets. It offers seed and venture capital to development stage companies and takes ownership positions in companies within life science and biotechnology. The company was founded on September 8, 1999 and is headquartered in Hellerup, Denmark. | Financial Conglomerates | Chief Executive Officer Chief Executive Officer | |
Sandoz AG
 Sandoz AG Pharmaceuticals: GenericHealth Technology Part of Novartis AG, Sandoz AG is a Swiss company that develops generic medicines and biosimilars. The company is based in Basel, Switzerland. | Pharmaceuticals: Generic | Chief Tech/Sci/R&D Officer Director of Finance/CFO | |
Xention Pharma Ltd.
 Xention Pharma Ltd. Pharmaceuticals: MajorHealth Technology Xention Pharma Ltd. develops and researches drugs. The firm develops novel therapies for the treatment of atrial fibrillation; modulators of IKur and IKACh for atrial fibrillation. The company was founded by John W. Word and is headquartered in Newmarket, the United kingdom. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Memory Pharmaceuticals Corp.
 Memory Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Memory Pharmaceuticals Corp. develops pharmaceutical products for the treatment of debilitating central nervous system (CNS) disorders such as Alzheimer's disease and schizophrenia. The company was founded by Axel Unterbeck in 1998 and is headquartered in Montvale, NJ. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member | |
| University of London | College/University | Graduate Degree Graduate Degree Undergraduate Degree | |
| The University of Colorado | College/University | Undergraduate Degree Undergraduate Degree | |
Evotec International GmbH
 Evotec International GmbH Miscellaneous Commercial ServicesCommercial Services Evotec International GmbH develops and provides drugs for the treatment of CNS disorders. It focuses on Alzheimer's disease and other neurological disorders. The company was founded in 1999 and is headquartered in Hamburg, Germany. | Miscellaneous Commercial Services | Chief Executive Officer Chief Executive Officer Chief Executive Officer Chief Executive Officer | |
| IOMAI CORPORATION | Biotechnology | Founder Chief Executive Officer Director/Board Member | |
| HEIDELBERG PHARMA AG | Pharmaceuticals: Major | Chairman Director/Board Member Director/Board Member | |
Roche Innovation Center Copenhagen A/S
 Roche Innovation Center Copenhagen A/S Pharmaceuticals: MajorHealth Technology Roche Innovation Center Copenhagen A/S discovers and develops drugs for the treatment of oncology, metabolic diseases, and infectious diseases. The firm manufactures a pipeline of drug candidates that act selectively on disease-related ribonucleic acid to provide patients with novel treatments for both rare and common diseases. It produces pre-clinical and clinical assets for the treatment of a range of diseases including oncology, metabolic diseases, and infectious diseases. The company was founded by Matts Lundwall and Mikael Ørum on January 1, 1998 and is headquartered in Horsholm, Denmark. | Pharmaceuticals: Major | Chief Executive Officer Chairman Director/Board Member | |
| London School of Economics & Political Science | College/University | Graduate Degree Corporate Officer/Principal | |
| University of Copenhagen | College/University | Doctorate Degree Doctorate Degree | |
| University of Zurich | College/University | Doctorate Degree Undergraduate Degree | |
| Ghent University | College/University | Graduate Degree Doctorate Degree | |
| Swiss Federal Institute of Technology | College/University | Corporate Officer/Principal Doctorate Degree Doctorate Degree | |
| University of Lausanne | College/University | Corporate Officer/Principal Corporate Officer/Principal Doctorate Degree | |
| Katholieke Universiteit Leuven | College/University | Graduate Degree Undergraduate Degree Doctorate Degree | |
| University of Bern | College/University | Undergraduate Degree Doctorate Degree | |
| Ludwig-Maximilians-Universität München | College/University | Doctorate Degree Doctorate Degree Graduate Degree | |
| Scandinavian International Management Institute | College/University | Masters Business Admin Masters Business Admin | |
RAG-Stiftung
 RAG-Stiftung Investment Trusts/Mutual FundsMiscellaneous RAG-Stiftung operates as a private foundation. It provides financing services for the perpetual mine management as well as the educational, scientific, and cultural projects related to coal mining in the Ruhr and Saar regions. The company was founded on June 26, 2007 and is headquartered in Essen, Germany. | Investment Trusts/Mutual Funds | Director/Board Member Director/Board Member | |
Inventages II
 Inventages II Investment ManagersFinance Inventages II invests in companies located in Bahamas. The fund focus on companies such as life science and consumer applications. It provides financing for seed, early and buyout capital requirements. | Investment Managers | Founder Founder | |
Vifor Pharma Management AG
 Vifor Pharma Management AG Pharmaceuticals: MajorHealth Technology Vifor Pharma Management AG develops and manufactures pharmaceuticals products for the treatment of iron deficiency. It also offers a diversified portfolio of prescription medicines as well as over-the-counter products. The company operates in the following key business areas: iron deficiency with and without anemia, kidney disease, infectious diseases/OTX products and consumer healthcare, with a focus on non-prescription products. Vifor Pharma Management was founded by Caspar Friedrich Hausmann in 1872 and is headquartered in Glattbrugg, Switzerland. | Pharmaceuticals: Major | Chief Executive Officer Director of Finance/CFO | |
SYNLAB International GmbH
 SYNLAB International GmbH Medical/Nursing ServicesHealth Services SYNLAB International GmbH offers medical laboratory services for practicing doctors, clinics and the pharmaceutical industry. It offers medical instruments, transfusion medicines, cytology, pathology, human genetics, and general hygiene services. The company was founded by Bartl Wimmer in 1998 and is headquartered in Munich, Germany. | Medical/Nursing Services | Chairman Director/Board Member | |
| VALNEVA | Biotechnology | Director/Board Member Director/Board Member Chief Executive Officer Director of Finance/CFO | |
| SANA AB | Biotechnology | Chairman Founder | |
Aptuit (Oxford) Ltd.
 Aptuit (Oxford) Ltd. Pharmaceuticals: MajorHealth Technology Part of Evotec SE, Aptuit (Oxford) Ltd. is a British pharmaceutical company that manufactures pharmaceutical products. The company is based in Abingdon, UK. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Saniona A/S
 Saniona A/S Miscellaneous Commercial ServicesCommercial Services Part of Saniona AB, Saniona A/S is a Danish company dedicated to improving the lives of rare disease patients worldwide through scientific innovation. The company focuses on Prader-Willi Syndrome, a rare genetic disorder characterized by insatiable appetite, abnormal growth and body composition, low muscle tone, and social/emotional/cognitive deficits. Saniona is a leader in the discovery of highly specific ion channel modulators, which is a validated approach to treating diseases such as diabetes, hypertension, and epilepsy. The company's robust ion channel drug discovery engine has led to the development of San711, a first-in-class positive allosteric modulator of GABAA ?3 receptors, and San903, a potential first-in-class inhibitor of the calcium-activated potassium ion channel, KCA3.1, both of which are in development for rare neuropathic, inflammatory, and fibrotic disorders. | Miscellaneous Commercial Services | Chairman Chairman | |
Xylocor Therapeutics, Inc.
 Xylocor Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Xylocor Therapeutics, Inc. engages in the biopharmaceutical company that develops gene therapy for people with advanced coronary artery disease. It focuses on developing product for patients with refractory angina with no treatment options and its secondary product for patients with cardiac tissue damage from heart attacks. The company was founded by Ronald Crystal and Todd Rosengart in 2013 and is headquartered in Malvern, PA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Momentum Gruppen A/S
 Momentum Gruppen A/S Electric UtilitiesUtilities Momentum Gruppen A/S provides and administrates solar and wind projects. It specializes in procuring, disseminating, and managing solar and wind projects. The firm assists in planning, construction, operational, asset life extension, repowering, decommissioning, and sales and sourcing of projects. The company was founded by Kim Madsen in 2005 and is headquartered in Roskilde, Denmark. | Electric Utilities | Director/Board Member Chairman | |
Evotec (Hamburg) GmbH
 Evotec (Hamburg) GmbH Miscellaneous Commercial ServicesCommercial Services Part of Evotec SE, Evotec (Hamburg) GmbH provides companies with administration and management services. The company is based in Hamburg, Germany. The CEO of the German company is Ralph Enno Spillner. | Miscellaneous Commercial Services | Chief Executive Officer Chief Executive Officer | |
Momentum Energy Group A/S
 Momentum Energy Group A/S Electric UtilitiesUtilities Momentum Energy Group A/S is a holding Danish company that provides electricity production services. The private company is based in Roskilde, Denmark and has subsidiaries in Denmark. The CEO of the company is Michael Shalmi. | Electric Utilities | Director/Board Member Chief Executive Officer |
Statistik
International
| Deutschland | 12 |
| Vereinigte Staaten | 11 |
| Schweiz | 11 |
| Dänemark | 10 |
| Vereinigtes Königreich | 6 |
Sektoral
| Health Technology | 23 |
| Consumer Services | 16 |
| Commercial Services | 6 |
| Finance | 4 |
| Utilities | 3 |
Operativ
| Director/Board Member | 623 |
| Corporate Officer/Principal | 233 |
| Chairman | 191 |
| Independent Dir/Board Member | 140 |
| Chief Executive Officer | 107 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Roland Sackers | 78 |
| Paul Sekhri | 62 |
| Friedrich von Bohlen und Halbach | 36 |
| Corey Goodman | 35 |
| Michael Shalmi | 30 |
| Alan Colowick | 30 |
| Bruno Montanari | 30 |
| Joseph deBethizy | 29 |
| Michel Gréco | 28 |
| Claus Tycho Bræstrup | 27 |
| David Ebsworth | 26 |
| Colin Bond | 25 |
| Douglas Williams | 25 |
| Monika Bütler | 25 |
| Kari Kapsch | 24 |
- Börse
- Insiders
- Werner Lanthaler
- Unternehmensverbindungen
